Young T. Hong, Tonny Veenith, Deborah Dewar, Joanne G. Outtrim, Vaithianadan Mani, Claire Williams, Sally Pimlott, Peter J. A. Hutchinson, Adriana Tavares, Roberto Canales, Chester A. Mathis, William E. Klunk, Franklin I. Aigbirhio, Jonathan P. Coles, Jean-Claude Baron, John D. Pickard, Tim D. Fryer, William Stewart, David K. Menon: Amyloid Imaging With Carbon 11–Labeled Pittsburgh Compound B for Traumatic Brain Injury. In: JAMA Neurology., S. , doi:10.1001/jamaneurol.2013.4847.
Abramov et al.: Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapsesNature Neuroscience, 2009; doi:10.1038/nn.2433
Cordy JM, Hussain I, Dingwall C, Hooper NM, Turner AJ: Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. In: Proc. Natl. Acad. Sci. U.S.A. 100. Jahrgang, Nr.20, September 2003, S.11735–40, doi:10.1073/pnas.1635130100, PMID 14504402, PMC 208827 (freier Volltext).
Fassbender K, Simons M, Bergmann C, et al: Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. In: Proc. Natl. Acad. Sci. U.S.A. 98. Jahrgang, Nr.10, Mai 2001, S.5856–61, doi:10.1073/pnas.081620098, PMID 11296263, PMC 33303 (freier Volltext).
Kukar T, Murphy MP, Eriksen JL, et al: Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. In: Nat. Med. 11. Jahrgang, Nr.5, Mai 2005, S.545–50, doi:10.1038/nm1235, PMID 15834426.
Green JD, Kreplak L, Goldsbury C, et al: Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. In: J. Mol. Biol. 342. Jahrgang, Nr.3, September 2004, S.877–87, doi:10.1016/j.jmb.2004.07.052, PMID 15342243.
nih.gov
ncbi.nlm.nih.gov
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer disease and Down syndrome. In: Proc. Natl. Acad. Sci. U.S.A. 82. Jahrgang, Nr.12, Juni 1985, S.4245–9, PMID 3159021, PMC 397973 (freier Volltext).
Strittmatter WJ, Weisgraber KH, Huang DY, et al: Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. In: Proc. Natl. Acad. Sci. U.S.A. 90. Jahrgang, Nr.17, September 1993, S.8098–102, PMID 8367470, PMC 47295 (freier Volltext).
Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K: Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. In: Proc. Natl. Acad. Sci. U.S.A. 95. Jahrgang, Nr.11, Mai 1998, S.6460–4, PMID 9600988, PMC 27798 (freier Volltext).
Cordy JM, Hussain I, Dingwall C, Hooper NM, Turner AJ: Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. In: Proc. Natl. Acad. Sci. U.S.A. 100. Jahrgang, Nr.20, September 2003, S.11735–40, doi:10.1073/pnas.1635130100, PMID 14504402, PMC 208827 (freier Volltext).
Fassbender K, Simons M, Bergmann C, et al: Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. In: Proc. Natl. Acad. Sci. U.S.A. 98. Jahrgang, Nr.10, Mai 2001, S.5856–61, doi:10.1073/pnas.081620098, PMID 11296263, PMC 33303 (freier Volltext).
Kukar T, Murphy MP, Eriksen JL, et al: Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. In: Nat. Med. 11. Jahrgang, Nr.5, Mai 2005, S.545–50, doi:10.1038/nm1235, PMID 15834426.
Green JD, Kreplak L, Goldsbury C, et al: Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. In: J. Mol. Biol. 342. Jahrgang, Nr.3, September 2004, S.877–87, doi:10.1016/j.jmb.2004.07.052, PMID 15342243.